An update on long-acting agents in HIV therapy

被引:1
作者
Pezzati, Laura [1 ,2 ]
Canavesi, Giada [1 ,2 ]
Rusconi, Stefano [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed & Clin Sci DIBIC, Milan, Italy
[2] Osped Nuovo Legnano, ASST Ovest Milanese, Infect Dis Unit, Legnano, Italy
关键词
AIDS; HIV; long acting antiretrovirals; pharmacokinetics; DAPIVIRINE VAGINAL RING; REVERSE-TRANSCRIPTASE INHIBITOR; CABOTEGRAVIR PLUS RILPIVIRINE; PREEXPOSURE PROPHYLAXIS; OPEN-LABEL; NEUTRALIZING ANTIBODIES; INJECTABLE CABOTEGRAVIR; ANTIRETROVIRAL THERAPY; INITIAL TREATMENT; TREATMENT-NAIVE;
D O I
10.2217/fvl-2023-0097
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Since the advent of highly active antiretroviral therapy, many efforts have been made to broaden the spectrum of possible regimens. Long-acting antiretrovirals, are particularly attractive, since they allow for less frequent dosing and can potentially overcome difficulties associated with daily tablet consumption, including the need for flexibility and privacy. In this article, we present a summary and update on currently available long-acting antiretrovirals and those under development and discuss issues related to their effective implementation.
引用
收藏
页码:881 / 893
页数:13
相关论文
共 103 条
[1]   Updating the Adherence-Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure Prophylaxis Among Cisgender Women [J].
Anderson, Peter L. ;
Marzinke, Mark A. ;
Glidden, David, V .
CLINICAL INFECTIOUS DISEASES, 2023, 76 (10) :1850-1853
[2]  
[Anonymous], 2021, FDA Approves cabenuva and vocabria for the treatment of HIV-1 infection
[3]  
[Anonymous], 2022, WHO recommends long-acting cabotegravir for HIV prevention
[4]  
[Anonymous], 2021, WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
[5]  
[Anonymous], Vocabria
[6]   Provision of injectable contraceptives by community health workers in sub-Saharan Africa: a systematic review of safety, acceptability and effectiveness [J].
Ayuk, Besong Eric ;
Yankam, Brenda Mbouamba ;
Saah, Farrukh Ishaque ;
Bain, Luchuo Engelbert .
HUMAN RESOURCES FOR HEALTH, 2022, 20 (01) :66
[7]   Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women [J].
Baeten, J. M. ;
Palanee-Phillips, T. ;
Brown, E. R. ;
Schwartz, K. ;
Soto-Torres, L. E. ;
Govender, V. ;
Mgodi, N. M. ;
Kiweewa, F. Matovu ;
Nair, G. ;
Mhlanga, F. ;
Siva, S. ;
Bekker, L. -G. ;
Jeenarain, N. ;
Gaffoor, Z. ;
Martinson, F. ;
Makanani, B. ;
Pather, A. ;
Naidoo, L. ;
Husnik, M. ;
Richardson, B. A. ;
Parikh, U. M. ;
Mellors, J. W. ;
Marzinke, M. A. ;
Hendrix, C. W. ;
van der Straten, A. ;
Ramjee, G. ;
Chirenje, Z. M. ;
Nakabiito, C. ;
Taha, T. E. ;
Jones, J. ;
Mayo, A. ;
Scheckter, R. ;
Berthiaume, J. ;
Livant, E. ;
Jacobson, C. ;
Ndase, P. ;
White, R. ;
Patterson, K. ;
Germuga, D. ;
Galaska, B. ;
Bunge, K. ;
Singh, D. ;
Szydlo, D. W. ;
Montgomery, E. T. ;
Mensch, B. S. ;
Torjesen, K. ;
Grossman, C. I. ;
Chakhtoura, N. ;
Nel, A. ;
Rosenberg, Z. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) :2121-2132
[8]  
Baeten JM, 2021, LANCET HIV, V8, pE87, DOI 10.1016/S2352-3018(20)30304-0
[9]  
Baker Z, 2021, JAIDS-J ACQ IMM DEF, V87, P944, DOI 10.1097/QAI.0000000000002674
[10]   Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption [J].
Bar, K. J. ;
Sneller, M. C. ;
Harrison, L. J. ;
Justement, J. S. ;
Overton, E. T. ;
Petrone, M. E. ;
Salantes, D. B. ;
Seamon, C. A. ;
Scheinfeld, B. ;
Kwan, R. W. ;
Learn, G. H. ;
Proschan, M. A. ;
Kreider, E. F. ;
Blazkova, J. ;
Bardsley, M. ;
Refsland, E. W. ;
Messer, M. ;
Clarridge, K. E. ;
Tustin, N. B. ;
Madden, P. J. ;
Oden, K. S. ;
O'Dell, S. J. ;
Jarocki, B. ;
Shiakolas, A. R. ;
Tressler, R. L. ;
Doria-Rose, N. A. ;
Bailer, R. T. ;
Ledgerwood, J. E. ;
Capparelli, E. V. ;
Lynch, R. M. ;
Graham, B. S. ;
Moir, S. ;
Koup, R. A. ;
Mascola, J. R. ;
Hoxie, J. A. ;
Fauci, A. S. ;
Tebas, P. ;
Chun, T-W .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) :2037-2050